Category : Search result: obesity treatment


Grateful Dead Fans Fund Ex-Member's Cancer Treatment

Devoted fans have mobilized to support former Grateful Dead keyboardist Tom Constanten, helping cover the costs of his cancer treatment. Read about this heartwarming story of community support.

PyroGenesis Signs Contract for Radioactive Waste Plasma Tech

Montreal's PyroGenesis Inc. signs a design contract with a European nuclear decommissioning specialist to develop plasma technology for treating low-level radioactive waste. Read about this innovative Canadian clean-tech solution.

Health Canada Approves Drug for Rare Disease

Health Canada has granted approval for a new pharmaceutical treatment targeting a rare disease, offering hope for patients. Learn about the regulatory decision and its impact.

Wheatley Water Plant Back in Service After Fire

The Wheatley Water Treatment Plant in Chatham-Kent is officially operational again after a 2023 fire. Get the details on the restoration and its importance for local water security.

Saskatchewan allows involuntary addiction treatment

The Saskatchewan government has tabled new legislation permitting involuntary treatment for severe addiction cases. Learn about the Compassionate Intervention Act, its safeguards, and the path to implementation in spring 2026.

Hims & Hers Acquires Livewell for Canadian Expansion

U.S. telehealth giant Hims & Hers acquires Canadian platform Livewell, positioning itself to launch generic semaglutide (Ozempic) in Canada as Novo Nordisk's patent lapses. The move targets a market where two-thirds of adults face weight-related health ch

Novo Nordisk to test obesity drug CagriSema in children

Novo Nordisk, maker of Wegovy, plans clinical trials for its experimental obesity medication CagriSema in overweight children and adolescents. Get the latest details on this significant development in pediatric health.

50-Bed Addiction Treatment Centre to Open in N.B.

A new 50-bed live-in facility for substance use treatment will open in New Brunswick in summer 2026 at Eagle's Eye View Cottages, marking a significant expansion of addiction recovery services in the province.

WHO Backs GLP-1 Treatments for Obesity Epidemic

The World Health Organization has officially endorsed GLP-1 receptor agonist treatments, including drugs like Ozempic, as a key tool to tackle the global obesity epidemic. Learn what this means for public health.

Eli Lilly cuts price of obesity drug Zepbound

Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.

Page 1 of 4